Valproate/Lamotrigine and Growth Retardation
Abstract
Growth and bone metabolism were evaluated in 27 boys and 26 girls, aged 3 to 17 years (mean 9.2 yrs), with epilepsy treated with valproate (VPA) and/or lamotrigine (LTG) for >2 years, in a study at McMaster University and Children’s Hospital, Hamilton, Ontario, Canada.
DOI: https://doi.org/10.15844/pedneurbriefs-15-12-4 | Journal eISSN: 2166-6482
Language: English
Page range: 91 - 92
Published on: Dec 1, 2001
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.